Close

Canaccord Genuity Reiterates a 'Buy' on Vivus (VVUS); Addressing Teratogenecity Issue Next Step Towards Qnexa Approval Mar 1, 2011 10:43AM
Canaccord Genuity Reiterates a 'Buy' on Vivus (VVUS); FDA Request Creates Delay, But We Remain Favorable on Qnexa Overall Jan 21, 2011 11:11AM
Notable Analyst Rating Changes 12/08: VVUS, FWLT, DOLE, ISIL Upgraded; NFLX, PCX, TXN, WTI Downgraded Dec 8, 2010 10:55AM
After-Hours Movers 12/07: VVUS, MIND, AVAV, COO Higher; MW, PPO, NFLX, STWD, MNTA, TXN Lower Dec 7, 2010 05:39PM
Canaccord Genuity Reiterates a 'Buy' on Vivus, Inc. (VVUS); Slight Shift in Strategy for Qnexa Resubmission; FDA Feedback Can Only Help Nov 9, 2010 11:13AM


Nov 2, 2010 03:41PM Canaccord Genuity Morning Coffee on Vivus (VVUS): A Big Problem?
Oct 25, 2010 11:33AM Canaccord Genuity Bullish on Vivus, Inc. (VVUS) Going Into 10/28 Qnexa PDUFA Date; Benign Delay Could Set Up H1/11 Approval
Sep 24, 2010 12:46PM FDA Decision On Avandia Is A Positive For VIVUS (VVUS) and Orexigen (OREX) - Analyst
Sep 22, 2010 12:34PM VIVUS (VVUS) Is Today's Top Performing Wall Street Upgrade
Sep 22, 2010 11:00AM Notable Analyst Rating Changes 09/22: VVUS, BAX, ALXN, DLB Upgraded; ADBE, NOK, PMCS, SOHU Downgraded
Sep 22, 2010 09:53AM Daily State of the Markets 09/22: Blame It On The Bonds (Again)
Sep 22, 2010 08:28AM Vivus (VVUS) Higher On Canaccord Genuity Upgrade to Buy
Sep 16, 2010 10:51AM Canaccord Genuity on Life Sciences/Biotechnology: Takeaways from the Sibutramine Panel
Jul 16, 2010 11:14AM Canaccord Genuity Reiterates a 'Hold' on VIVUS (VVUS); Negative Ad Com Vote Means Uncertain Future for Qnexa, Approval Still Possible